Bayer (BAYRY) stock drops as the company projected adjusted earnings that fell short of average analysts’ estimates for 2026.

As outlined by Bayer, the company announced in August 2024 that it planned to invest more than $100 million into its St. Louis campuses while putting portions of the Creve Coeur property on the market ...

ADJUSTED EARNINGS FORECAST: Bayer is expected to report quarterly earnings before interest, taxes, depreciation and amortization before special items of 1.92 billion euros, according to the same ...

Bill Anderson, Bayer's chief executive, updates investors on his turnaround plan for the German drugs and chemicals firm following its disastrous Monsanto acquisition.

Announced today, Bayer’s subsidiary Monsanto has reached a class settlement deal—pending court approval—to reach the company’s goal of containing glyphosate litigation. The deal includes $7.25 billion ...

Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in 2026. | The primary growth drivers in Bayer’s pharma sector—Nubeqa and ...

German agrichemical giant Bayer said Wednesday it made a loss of 3.62 billion euros ($4.20 billion) in 2025 after it booked extra charges related to claims that its popular weedkiller ...

Bayer’s $7.25B Roundup settlement gains initial approval in Missouri, potentially resolving thousands of cancer lawsuits tied to glyphosate exposure.

Bayer is exiting the seed treatment equipment business in the United States to help the company’s finances, according to an email sent to customers that was seen by Reuters on Wednesday. The German ...

Agrochemical maker Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve ...